#NewAseBioAlly | “AseBio provides us with the opportunity to be part of an ecosystem facing significant challenges in the near future”

AseBio. What does your company's work bring to the table and what is its strength?

Gemma Colomer y Arian Gallardo. At Fieldfisher, we are a leading firm in providing legal advice to companies in the Life Sciences sector, especially in the areas of regulatory, R&D&I, and Tech&Data. 

We offer a full range of services to the pharmaceutical, biotechnology, and MedTech industries, including assisting companies in their day-to-day activities, advising on market access issues, technology development agreements, and specific collaboration agreements with various research system agents, clinical trials, and other studies, as well as all regulatory issues arising from the commercialization of products. We also provide legal assistance and representation in complex contentious litigation before public administrations, courts, and commercial code of conduct bodies. 

With our extensive experience in the sector, we bring an innovative and strategic approach that combines technical knowledge and business vision.

AseBio. What is AseBio for you?

Gemma Colomer y Arian Gallardo. We are aware that in recent years, biotechnology companies have been making significant advances in research and will play a fundamental role in the development of new products and services in the future, becoming one of the main drivers of progress within the life sciences sector. Therefore, we believe that AseBio, as an association that brings together and represents various entities in the technology and research sector that develop activities in the field of biotechnology in Spain, provides us with the opportunity to be part of an ecosystem facing significant challenges in the near future.

AseBio. When did you first hear about AseBio?

Gemma Colomer y Arian Gallardo. We have been following AseBio's projects and achievements for some time, but it was not until the last year that we realized the need to actively participate and collaborate by contributing our experience and vision to its members.

AseBio. What do you expect from being part of an association like AseBio?

Gemma Colomer y Arian Gallardo. We believe that our alliance with AseBio will provide us with a meeting place with the various agents involved in the biotechnology sector in Spain, allowing us to understand their needs and concerns, and thus provide support tailored to the needs of the members.

AseBio. What is the biggest challenge facing the biotech sector or your company?

Gemma Colomer y Arian Gallardo. As expert regulatory advisors, we see that although European and national regulations strive to adapt, the market and the speed of new advances and their needs are ahead, often placing us in situations or grey areas that require specific and sometimes complex analyses to control potential risks. 

On a more personal level, as legal advisors, our challenge is to ensure that, with our experience and way of working, AseBio members perceive us as a partner in the development of their projects.